These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18484357)

  • 21. Using UHPLC Q-Trap/MS as a complementary technique to in-depth mine UPLC Q-TOF/MS data for identifying modified nucleosides in urine.
    Lu Z; Wang Q; Wang M; Fu S; Zhang Q; Zhang Z; Zhao H; Liu Y; Huang Z; Xie Z; Yu H; Gao X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1051():108-117. PubMed ID: 28340480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleoside excretion in breast cancer: comparison with other biochemical tumour-index-substances.
    Coombes RC; Powles TJ; Gehrke CW; Waalkes TP; Neville AM
    Invest Cell Pathol; 1979; 2(1):11-4. PubMed ID: 511604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids.
    Davis GE; Suits RD; Kuo KC; Gehrke CW; Waalkes TP; Borek E
    Clin Chem; 1977 Aug; 23(8):1427-35. PubMed ID: 872405
    [No Abstract]   [Full Text] [Related]  

  • 24. Modified Nucleosides - Molecular Markers Suitable for Small-volume Cancer?
    Opitz P; Herbarth O; Seidel A; Boehm A; Fischer M; Mozet C; Dietz A; Wichmann G
    Anticancer Res; 2018 Nov; 38(11):6113-6119. PubMed ID: 30396926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry.
    Cho SH; Jung BH; Lee SH; Lee WY; Kong G; Chung BC
    Biomed Chromatogr; 2006 Nov; 20(11):1229-36. PubMed ID: 16799933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial neural network classification based on high-performance liquid chromatography of urinary and serum nucleosides for the clinical diagnosis of cancer.
    Yang J; Xu G; Kong H; Zheng Y; Pang T; Yang Q
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):27-33. PubMed ID: 12383477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Capillary electrophoresis-mass spectrometry for direct determination of urinary modified nucleosides. Evaluation of synthetic urine as a surrogate matrix for quantitative analysis.
    Rodríguez-Gonzalo E; Hernández-Prieto R; García-Gómez D; Carabias-Martínez R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 942-943():21-30. PubMed ID: 24212140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hsu WY; Lin WD; Tsai Y; Lin CT; Wang HC; Jeng LB; Lee CC; Lin YC; Lai CC; Tsai FJ
    Clin Chim Acta; 2011 Sep; 412(19-20):1861-6. PubMed ID: 21740897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential excretion of modified nucleosides in adult acute leukemia.
    Heldman DA; Grever MR; Trewyn RW
    Blood; 1983 Feb; 61(2):291-6. PubMed ID: 6571786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers.
    Struck W; Siluk D; Yumba-Mpanga A; Markuszewski M; Kaliszan R; Markuszewski MJ
    J Chromatogr A; 2013 Mar; 1283():122-31. PubMed ID: 23465127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of urinary nucleosides. I. Optimisation of high performance liquid chromatography/electrospray mass spectrometry.
    Dudley E; El-Sharkawi S; Games DE; Newton RP
    Rapid Commun Mass Spectrom; 2000; 14(14):1200-7. PubMed ID: 10918368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced levels of modified nucleosides in the urine of autistic children. Preliminary studies.
    Bobrowska-Korczak B; Gątarek P; Rosiak A; Giebułtowicz J; Kałużna-Czaplińska J
    Anal Biochem; 2019 Apr; 571():62-67. PubMed ID: 30771338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development, validation and application of a fast analytical methodology for the simultaneous determination of DNA- and RNA-derived urinary nucleosides by liquid chromatography coupled to tandem mass spectrometry.
    Rodríguez-Gonzalo E; Herrero-Herrero L; García-Gómez D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1019():132-9. PubMed ID: 26565068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary modified nucleosides as novel biomarkers for diagnosis and prognostic monitoring of urothelial bladder cancer.
    Zhang YR; Shi L; Wu H; Tang DD; Wang SM; Liu HM; Zhang LR; Song DK
    Tumori; 2014; 100(6):660-6. PubMed ID: 25688500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A fast capillary electrophoresis method for separation and quantification of modified nucleosides in urinary samples.
    Jiang Y; Ma Y
    Anal Chem; 2009 Aug; 81(15):6474-80. PubMed ID: 19552424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of urinary modified nucleosides and ribosylated metabolites in humans via combined ESI-FTICR MS and ESI-IT MS analysis.
    Bullinger D; Fux R; Nicholson G; Plontke S; Belka C; Laufer S; Gleiter CH; Kammerer B
    J Am Soc Mass Spectrom; 2008 Oct; 19(10):1500-13. PubMed ID: 18657436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of urinary nucleosides as potential cancer markers determined using LC-MS technique.
    Struck-Lewicka W; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2014 Dec; 101():50-7. PubMed ID: 24840632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolome analysis via comprehensive two-dimensional liquid chromatography: identification of modified nucleosides from RNA metabolism.
    Willmann L; Erbes T; Krieger S; Trafkowski J; Rodamer M; Kammerer B
    Anal Bioanal Chem; 2015 May; 407(13):3555-66. PubMed ID: 25736241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MALDI-TOF MS analysis of urinary nucleosides.
    Kammerer B; Frickenschmidt A; Gleiter CH; Laufer S; Liebich H
    J Am Soc Mass Spectrom; 2005 Jun; 16(6):940-7. PubMed ID: 15907708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.